The Lupus Research Alliance is the world’s leading private funder of lupus research.
News
New use for OMRF brain cancer treatment could extend lives
In a new study, the OMRF compound OKN-007 is being combined with the current standard-of-care medication for glioblastoma.
OMRF scientists discover potential therapeutic target for lymphedema
Lymphedema is a disease characterized by dramatic and painful swelling in the limbs that often leads to infections.
OMRF named Oklahoma’s top workplace
We have now won the top prize two of the past three years.
Oklahoma teen lives with unique skeletal disorder
Sydney Rutz is one in five billion.
OMRF accepting 2020 Fleming Scholar applications
The application deadline is Feb. 1.
